ThePrint
@ThePrintIndia
A new study by the Massachusetts Institute of Technology shows that some widely-used cancer therapies may fall short not because the drugs fail, but because tumours are biologically primed to evade them.
Read more
Read more
ThePrint
MIT study answers why some cancer treatments fail. Most tumours have active backdoor pathways
Some cancer treatments fail not because the drugs were ineffective, but because tumours design a network to evade them.
1 1 836
Обсуждение 1
Обсуждение не доступно в веб-версии. Чтобы написать комментарий, перейдите в приложение Telegram.
Обсудить в Telegram